ProCE Banner Activity

ExpressPoints
Advances in Relapsed/Refractory Myeloma: Practical Guidance for Newly Approved and Emerging Therapies

Slideset Download
Download this short summary slideset of key takeaways from this CCO webinar focused on individualized management of patients with relapsed/refractory multiple myeloma.

Released: May 14, 2021

Expiration: May 13, 2022

No longer available for credit.

Share

Faculty

Sagar Lonial

Sagar Lonial, MD, FACP

Chair and Professor 
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

Kathryn Maples

Kathryn Maples, PharmD, BCOP

Clinical Pharmacy Specialist, Multiple Myeloma
Department of Pharmacy
Emory Healthcare
Winship Cancer Institute
Atlanta, Georgia

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

Bristol Myers Squibb

Karyopharm Therapeutics

Faculty Disclosure

Primary Author

Sagar Lonial, MD, FACP

Chair and Professor 
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

Kathryn Maples, PharmD, BCOP

Clinical Pharmacy Specialist, Multiple Myeloma
Department of Pharmacy
Emory Healthcare
Winship Cancer Institute
Atlanta, Georgia